Advanced search
Publication Cover
Journal of Market Access & Health Policy Volume 11, 2023 - Issue 1
Journal homepage
689
Views
0
CrossRef citations to date
0
Altmetric
Original Research Article

Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey

Ahmet Fuata Carmel Medical Practice, Nunnery Lane, Darlington, UKView further author information
,
Emmanuel Akob Cardiology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UKView further author information
,
David Hargrovesc Stroke Medicine, East Kent Hospitals University NHS Foundation Trust, Canterbury, UKView further author information
,
Douglas Holdend Wickenstones Ltd, Carlow, IrelandView further author information
,
Amrit Caleyachettyd Wickenstones Ltd, Carlow, IrelandView further author information
,
Matthew Carterd Wickenstones Ltd, Carlow, IrelandView further author information
,
James Harrisd Wickenstones Ltd, Carlow, IrelandView further author information
,
Carol Robertse Bayer PLC, Reading, UKView further author information
,
Nnanyelu Nzeakore Bayer PLC, Reading, UKView further author information
,
Burcu Vardarf Bayer AG, Berlin, GermanyView further author information
&
Helen Williamsg Department of Medicines Optimisation, South East London Integrated Care System, and UCL Partners, London, UKCorrespondence[email protected]
View further author information
 show all
Article: 2267327 | Received 08 Jun 2023, Accepted 03 Oct 2023, Published online: 29 Oct 2023

References

  • Pearsons A, Hanson CL, Gallagher R, et al. Atrial fibrillation self-management: a mobile telephone app scoping review and content analysis. Eur J Cardiovasc Nurs. 2021;20(4):305–11. doi: 10.1093/eurjcn/zvaa014
  • Elezi S, Qerkini G, Bujupi L, et al. Management and comorbidities of atrial fibrillation in patients admitted in cardiology service in Kosovo-a single-center study. Anadolu kardiyoloji dergisi : AKD = Anatolian J cardiol. 2010;10(1):36–40. doi: 10.5152/akd.2010.008
  • Kwok CS, Lip GYH. The patient pathway review for atrial fibrillation. Crit Pathw Cardiol. 2022;21(2):96–102. doi: 10.1097/HPC.0000000000000280
  • Elliott AD, Middeldorp ME, Van Gelder IC, et al. Epidemiology and modifiable risk factors for atrial fibrillation. Nat Rev Cardiol. 2023;20(6):404–417. doi: 10.1038/s41569-022-00820-8
  • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–1151. doi: 10.1056/NEJMoa0905561
  • Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883–891. doi: 10.1056/NEJMoa1009638
  • Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–992. doi: 10.1056/NEJMoa1107039
  • Chen A, Stecker E, Warden BA. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13):e017559. doi: 10.1161/JAHA.120.017559
  • Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093–2104. doi: 10.1056/NEJMoa1310907
  • García Rodríguez LA, Martín-Pérez M, Vora P, et al. Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK. BMJ Open. 2019;9(9):e031341. doi: 10.1136/bmjopen-2019-031341
  • Hindricks G, Potpara T, Dagres N, et al. ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm association (EHRA) of the ESC. Eur Heart J. 2020;42(5):373–498.
  • Shen NN, Zhang C, Hang Y, et al. Real-world prevalence of Direct oral anticoagulant off-label doses in atrial fibrillation: an epidemiological meta-analysis. Front Pharmacol. 2021;12:581293. 1663-9812 (Print).
  • Caso V, de Groot JR, Sanmartin Fernandez M, et al. Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis. Heart. 2022;109(3):178–185. doi: 10.1136/heartjnl-2022-321114
  • Network A. AHSN Network national programme from April 2018-March 2020 April 2018. https://www.ahsnnetwork.com/about-academic-health-science-networks/national-programmes-priorities/atrial-fibrillation.
  • Converse L, Barrett K, Rich E, et al. Methods of Observing Variations in physicians’ decisions: the Opportunities of clinical vignettes. J Gen Intern Med. 2015;30 Suppl 3(Suppl 3):S586–594. doi: 10.1007/s11606-015-3365-8
  • Stata Statistical Software: Release 17 [Internet]. StataCorp LLC. 2021.
  • Papanastasiou CA, Theochari CA, Zareifopoulos N, et al. Atrial fibrillation is associated with cognitive impairment, all-cause dementia, vascular dementia, and Alzheimer’s disease: a systematic review and meta-analysis. J Gen Intern Med. 2021;36(10):3122–3135. 1525-1497 (Electronic). doi: 10.1007/s11606-021-06954-8
  • Osasu YM, Cooper R, Mitchell C. Patients’ and clinicians’ perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis. BMC Fam Pract. 2021;22(1):254. doi: 10.1186/s12875-021-01590-x
  • Proietti M, Camera M, Gallieni M, et al. Use and prescription of Direct oral anticoagulants in older and frail patients with atrial fibrillation: a multidisciplinary consensus document. J Pers Med. 2022;12(3):469. doi: 10.3390/jpm12030469
  • Guo Q, Du X, Ma C-S. Atrial fibrillation and frailty. J Geriatr Cardiol. 2020;17(2):105–109. doi: 10.11909/j.issn.1671-5411.2020.02.007
  • Kim D, Yang PS, Sung JH, et al. Effectiveness and safety of anticoagulation therapy in frail patients with atrial fibrillation. Stroke. 2022;53(6):1873–1882. doi: 10.1161/STROKEAHA.121.036757
  • Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42. doi: 10.1186/1748-5908-6-42
  • Pritchett RV, Bem D, Turner GM, et al. Improving the prescription of oral anticoagulants in atrial fibrillation: a systematic review. Thromb Haemost. 2019;119(2):294–307. doi: 10.1055/s-0038-1676835

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.